Alizadeh, M.; Broomand Lomer, N.; Azami, M.; Khalafi, M.; Shobeiri, P.; Arab Bafrani, M.; Sotoudeh, H.
Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme. Cancers 2023, 15, 4429.
https://doi.org/10.3390/cancers15184429
AMA Style
Alizadeh M, Broomand Lomer N, Azami M, Khalafi M, Shobeiri P, Arab Bafrani M, Sotoudeh H.
Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme. Cancers. 2023; 15(18):4429.
https://doi.org/10.3390/cancers15184429
Chicago/Turabian Style
Alizadeh, Mohammadreza, Nima Broomand Lomer, Mobin Azami, Mohammad Khalafi, Parnian Shobeiri, Melika Arab Bafrani, and Houman Sotoudeh.
2023. "Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme" Cancers 15, no. 18: 4429.
https://doi.org/10.3390/cancers15184429
APA Style
Alizadeh, M., Broomand Lomer, N., Azami, M., Khalafi, M., Shobeiri, P., Arab Bafrani, M., & Sotoudeh, H.
(2023). Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme. Cancers, 15(18), 4429.
https://doi.org/10.3390/cancers15184429
